サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386204

小児用ワクチン市場レポート：2030年までの動向、予測、競合分析

Pediatric Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

小児用ワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

小児用ワクチンの動向と予測

世界の小児用ワクチン市場は、2024年から2030年までのCAGRが5.7%で、2030年には推定308億米ドルに達すると予想されています。この市場の主な促進要因は、保護者や医療関係者の間でこれらのワクチンの利点に対する認識が高まっていること、混合ワクチンに対する需要が高まっていること、そして新しく革新的な小児用ワクチンが継続的に開発されていることです。世界の小児用ワクチン市場の将来は、感染症、がん、アレルギー、肺炎球菌性疾患、インフルエンザ、麻疹、おたふくかぜ、風疹（MMR）の各アプリケーションにおける機会によって有望視されています。

小児用ワクチン市場の洞察

Lucintelの予測では、肺炎球菌および髄膜炎菌性疾患において、これらのウイルスに対する抑制力を提供するために結合型が大きく使用されるため、予測期間中に最も高い成長が見込まれます。

北米は、強固なヘルスケアインフラの存在、予防接種プログラムに対する政府の積極的な取り組み、小児人口の増加により、予測期間中に最も高い成長が見込まれています。

市場規模・推計：小児用ワクチンの市場規模を金額（億米ドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメンテーション分析：ワクチンタイプ別、技術別、用途別、地域別の小児用ワクチン市場規模（金額（$B）ベース）。

地域別分析：小児用ワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。

成長機会：小児用ワクチンの種類、技術、用途、地域別の成長機会分析。

戦略分析：小児用ワクチン市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の小児用ワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
  • 世界の小児用ワクチン市場動向（2018年～2023年）と予測（2024年～2030年）
  • ワクチンタイプ別の世界の小児用ワクチン市場
    • 一価
    • 多価
  • 技術別の世界の小児用ワクチン市場
    • 弱毒性
    • 不活化
    • サブユニット
    • トキソイド
    • 共役
    • その他
  • 用途別の世界の小児用ワクチン市場
    • 感染症
    • がん
    • アレルギー
    • 肺炎球菌疾患
    • インフルエンザ
    • 麻疹、おたふく風邪、風疹（MMR）
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の小児用ワクチン市場
  • 北米の小児用ワクチン市場
  • 欧州の小児用ワクチン市場
  • アジア太平洋の小児用ワクチン市場
  • その他の地域の小児用ワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • ワクチンタイプ別の世界の小児用ワクチン市場の成長機会
    • 技術別の世界の小児用ワクチン市場の成長機会
    • 用途別の世界の小児用ワクチン市場の成長機会
    • 地域別の世界の小児用ワクチン市場の成長機会
  • 世界の小児用ワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の小児用ワクチン市場の能力拡大
    • 世界の小児用ワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute of India
目次

Pediatric Vaccine Trends and Forecast

The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

A more than 150-page report is developed to help in your business decisions.

Pediatric Vaccine by Segment

The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.

Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent
  • Multivalent

Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Conjugate
  • Others

Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Cancer
  • Allergy
  • Pneumococcal Disease
  • Influenza
  • Measles, Mumps, and Rubella (Mmr)
  • Others

Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pediatric Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Pediatric Vaccine Market Insights

Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Features of the Global Pediatric Vaccine Market

Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).

Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pediatric vaccine market size?

Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.

Q.2 What is the growth forecast for pediatric vaccine market?

Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?

Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

Q4. What are the major segments for pediatric vaccine market?

Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.

Q5. Who are the key pediatric vaccine market companies?

Answer: Some of the key pediatric vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Q6. Which pediatric vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pediatric Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pediatric Vaccine Market by Vaccine Type
    • 3.3.1: Monovalent
    • 3.3.2: Multivalent
  • 3.4: Global Pediatric Vaccine Market by Technology
    • 3.4.1: Live Attenuated
    • 3.4.2: Inactivated
    • 3.4.3: Subunit
    • 3.4.4: Toxoid
    • 3.4.5: Conjugate
    • 3.4.6: Others
  • 3.5: Global Pediatric Vaccine Market by Application
    • 3.5.1: Infectious Disease
    • 3.5.2: Cancer
    • 3.5.3: Allergy
    • 3.5.4: Pneumococcal Disease
    • 3.5.5: Influenza
    • 3.5.6: Measles, Mumps, and Rubella (MMR)
    • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pediatric Vaccine Market by Region
  • 4.2: North American Pediatric Vaccine Market
    • 4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.3: European Pediatric Vaccine Market
    • 4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.4: APAC Pediatric Vaccine Market
    • 4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.5: ROW Pediatric Vaccine Market
    • 4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Pediatric Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Pfizer
  • 7.5: Johnson & Johnson
  • 7.6: Bharat Biotech International
  • 7.7: Serum Institute of India